Detailed answers about ARTIFICIAL HEALTH CARE INTELLIGENCE LIMITED, including incorporation, status, business activity, and accounts information.
When was ARTIFICIAL HEALTH CARE INTELLIGENCE LIMITED founded?
ARTIFICIAL HEALTH CARE INTELLIGENCE LIMITED was officially incorporated on 3 January 2025 and is registered under company number 16161477. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ARTIFICIAL HEALTH CARE INTELLIGENCE LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ARTIFICIAL HEALTH CARE INTELLIGENCE LIMITED?
ARTIFICIAL HEALTH CARE INTELLIGENCE LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ARTIFICIAL HEALTH CARE INTELLIGENCE LIMITED do?
ARTIFICIAL HEALTH CARE INTELLIGENCE LIMITED operates in the following sectors: 62012 - Business and domestic software development, 62020 - Information technology consultancy activities. These SIC codes provide insight into the company's business activities and industry focus.
What is ARTIFICIAL HEALTH CARE INTELLIGENCE LIMITED's registered address?
The registered office address of ARTIFICIAL HEALTH CARE INTELLIGENCE LIMITED is 124 CITY ROAD, LONDON, UNITED KINGDOM, EC1V 2NX. This is the official address filed with Companies House for legal and statutory correspondence.
Is ARTIFICIAL HEALTH CARE INTELLIGENCE LIMITED financially stable?
Financial accounts for ARTIFICIAL HEALTH CARE INTELLIGENCE LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.